Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth
11:05am, Wednesday, 29'th Oct 2025
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Tuesday, 28'th Oct 2025
McKesson (MCK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Tuesday, 28'th Oct 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing
06:51pm, Friday, 24'th Oct 2025
McKesson (MCK) reached $801.67 at the closing of the latest trading day, reflecting a +1.1% change compared to its last close.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Thursday, 23'rd Oct 2025
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
08:37am, Monday, 20'th Oct 2025
McKesson joins leading distribution service providers as authorized U.S. distributor of LYMPHIR CRANFORD, N.J. , Oct. 20, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR),
McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing
06:51pm, Friday, 17'th Oct 2025
McKesson (MCK) reached $786 at the closing of the latest trading day, reflecting a +1.36% change compared to its last close.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 15'th Oct 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
07:00pm, Tuesday, 14'th Oct 2025
In the closing of the recent trading day, McKesson (MCK) stood at $781.9, denoting a +1.61% move from the preceding trading day.
Here's Why McKesson (MCK) is a Strong Momentum Stock
10:51am, Tuesday, 14'th Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson Corporation Transforming Towards High-Margin Operations: Why I Choose To Buy
04:05am, Saturday, 11'th Oct 2025
McKesson Corporation is transforming from a traditional distributor to a tech-enabled healthcare services leader, focusing on high-margin specialty and digital solutions. Recent acquisitions (PRISM Vi
McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity
02:08am, Saturday, 11'th Oct 2025
McKesson Corporation is rated 'Buy' due to its transformation into a higher-growth, higher-margin healthcare services platform focused on Oncology & Multispecialty and Prescription Technology Solution
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
10:01am, Thursday, 09'th Oct 2025
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
12:51pm, Wednesday, 08'th Oct 2025
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-
How to trade the health care break out
02:24pm, Monday, 06'th Oct 2025
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
